Search the Newsreel

Van Eck Associates (NNE) reports 7.3% Nano Nuclear Energy stake in 13G/A

Van Eck Associates Corporation has filed an amended Schedule 13G, disclosing a beneficial ownership of 7.3% in Nano Nuclear Energy Inc., totaling 3,819,847 ordinary shares. Van Eck retains sole voting and dispositive power over these shares, which are also linked to the VanEck Uranium …

Bionano Genomics (BNGO) investor discloses 9.9% position via warrants

CVI Investments, Inc. and Heights Capital Management, Inc. have disclosed a 9.9% beneficial ownership in Bionano Genomics (BNGO) through warrants. This position, amounting to 1,307,135 shares, is subject to ownership caps of 4.99% and 9.99% for different portions of the warrants. The ownership percentage …

Nano Labs Launches NBNB Program to Build Real-World Asset Infrastructure on BNB Chain

Nasdaq-listed Nano Labs has initiated the "Next Big BNB Program" (NBNB) on BNB Chain to develop a compliance-first infrastructure for real-world asset tokenization. This Hong Kong-based Web3 infrastructure provider aims to bridge traditional assets like equities, bonds, and real estate with blockchain technology through …

NANO Nuclear Announces Participation in Several Investor Conferences

NANO Nuclear Energy Inc. announced its participation in several upcoming investor conferences, including Citi’s Natural Resources Conference, Needham Virtual Industrial Tech, Robotics, & Power 1x1 Conference, Barclays 40th Annual Energy-Power Conference, and Wedbush West Coast Technology Tour. The company, a leader in advanced nuclear …

JD Sports & Oxford Nanopore: Stock market week ahead – 17-21 Aug

Nano Nuclear Energy Inc. (NASDAQ:NNE) Given Average Recommendation of "Moderate Buy" by Brokerages

Eight brokerages have given Nano Nuclear Energy Inc. (NASDAQ:NNE) a consensus recommendation of "Moderate Buy," with an average 12-month price target of $41.60. The company recently reported a narrower-than-expected Q3 loss of ($0.19) per share, though revenue of $0.21 million fell short of estimates. …

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)

This article provides an overview of analyst ratings for three healthcare companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA), and PolyPid (PYPD). BioNano Genomics received a "Buy" rating with a $4.00 price target, while Liquidia Technologies was given a "Hold" rating and a $90.00 price …

Q3 2026 NanoXplore Inc Earnings Call Transcript

SMR Earnings Miss Fails To Shake Nuclear AI Trade: Here’s Why Retail Is Watching OKLO, NNE Next Week

NANO Nuclear Energy (NASDAQ: NNE) - What's Next Following Third Quarter Results?

NANO Nuclear Energy (NASDAQ: NNE) announced its third-quarter fiscal year 2026 results, highlighting significant progress in its microreactor development and business expansion. Key achievements include the NRC accepting the Construction Permit Application for the KRONOS MMR Energy System, the acquisition of Secured Transportation Systems …

Nanobiotix S.A. (NBTX) investor group reports 9.4% stake and pre-funded warrants

An investor group led by Invus Public Equities, L.P. has reported a 9.4% beneficial ownership stake in Nanobiotix S.A. (NBTX), comprising 4,483,275 ordinary shares and 345,099 pre-funded warrants. The warrants are exercisable at Euro 0.03 per share and expire in May 2036. This filing, …

Benchmark reiterates Buy on NANO Nuclear stock, $45 target

Benchmark reiterates Buy on NANO Nuclear stock, $45 target By Investing.com

Nano Nuclear Energy Inc. stock Analysis: Short-Term Bounce vs Longer-Term Downtrend

Nano Nuclear Energy Inc. stock (NNE) closed at $19.03, showing a short-term bounce but remaining within a larger downtrend, significantly below its 200-day EMA. The stock exhibits conflicting signals across different timeframes: short-term bullish momentum on hourly charts is losing steam, while the daily …

NANO Nuclear Energy Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:NNE)

NANO Nuclear Energy Inc. (NNE) published its Q3 2026 earnings call presentation on August 13, 2026. The company reported an EPS of -$0.20, beating estimates by $0.04, but revenue of $214.04K missed expectations by $177.39K. This article highlights the availability of the slide deck …

Transcript : NANO Nuclear Energy Inc., Q3 2026 Earnings Call, Aug 12, 2026

NANO Nuclear Stock (NNE): $580 Million Liquidity Cushion Meets a $214,000 Revenue Test

Nano-X Imaging (NASDAQ: NNOX) Optimizes Nanox.AI Medical Imaging Framework for Intel Core Ultra Processors

Nano-X Imaging Ltd. (NASDAQ: NNOX) announced that its subsidiary Nanox.AI has optimized its medical imaging AI application framework for Intel Core Ultra processors using the Intel OpenVINO toolkit. This optimization enables healthcare facilities to deploy CT imaging AI applications on on-premise edge devices, keeping …

Earnings call transcript: NANO Nuclear beats Q3 2026 EPS forecast, shares edge up

Compte rendu d’appel aux résultats : NANO Nuclear dépasse les prévisions de BPA au T3 2026

Nano Nuclear Energy Inc. (NNE) Reports Q3 Loss, Misses Revenue Estimates

Earnings Flash (NNE) Nano Nuclear Energy Posts Fiscal Q3 Loss $0.19 per Share, vs. FactSet Est of $0.26 Loss

Nano Nuclear Energy (NNE) grows cash to $298M while advancing microreactor and fuel businesses

Nano Nuclear Energy Inc. (NNE) reported a net loss of $10.1 million for the quarter ended June 30, 2026, and a nine-month net loss of $25.8 million, while significantly increasing its cash reserves to $298.5 million. The company's total assets reached $628 million, supported …

NANO Nuclear Reports Q3 FY 2026 Financial Results and Provides Business Update

NANO Nuclear Energy Inc. reported strong Q3 FY 2026 financial results, showcasing significant progress in its microreactor development and vertical integration strategy. Key achievements include the NRC's acceptance of the KRONOS MMR™ Energy System's construction permit application and the acquisition of Secured Transportation Systems, …

Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4

Maxim Group has reiterated its Buy rating for Bionano Genomics (BNGO.US), along with a maintained target price of $4. This indicates a continued positive outlook from the firm regarding the company's stock performance and valuation.

Should You Buy, Sell or Hold OKLO Stock Post First Revenues?

Oklo Inc. (OKLO) reported its first revenues in Q2 2026, marking a significant operational milestone for its advanced nuclear strategy, including criticality at its Groves isotope facility. However, the company's losses widened, and spending increased due to investments in engineering, hiring, and project development. …

Nuclear Energy Stocks For AI Power Demand Starting With Duke Energy

This article examines three nuclear energy stocks that could benefit from increasing demand for reliable, low-carbon electricity, driven by factors like AI data centers and energy security goals. It highlights NANO Nuclear Energy, a pre-revenue microreactor developer; Duke Energy, a large regulated utility with …

Nano Dimension (NNDM) Projected to Release Earnings on Wednesday

NANO: $18.2M net assets, $63M+ non-dilutive capital, and Candiac expansion 85% complete

Weebit Nano (ASX:WBT) Semiconductor IP Story Gains Attention as Licensing Momentum Builds

Nano One Materials Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

NANO Nuclear Energy Stock And 2 More Picks For AI Data Center Power

This article identifies NANO Nuclear Energy (NNE), Duke Energy (DUK), and Fluor (FLR) as three nuclear energy stocks with potential for investors interested in AI data center power. NANO Nuclear Energy focuses on microreactors and fuel supply, Duke Energy provides regulated nuclear power with …

Bionano Genomics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:BNGO)

Bionano Genomics, Inc. published its 2026 Q2 earnings call presentation. The slide deck was released in conjunction with the company's Q2 earnings call. This article was written by SA Transcripts, which publishes thousands of quarterly earnings call transcripts.